Solasto reports record Q1 sales, boosts shareholder returns

Solasto Corporation reported record Q1 net sales of 34,926 million yen, up 2.4% year-on-year, driven by a 3.0% increase in its medical business to 18,310 million yen. Operating profit fell 4.1% to 1,643 million yen due to planned investments in employee treatment and IT systems.

The company raised its annual dividend to 22 yen per share from 20 yen and announced a 1,400 million yen share buyback program for up to 4.4 million shares.